Get started
Author

Jessica L. Mitchell

Observed names: J. Mitchell, Jessica L Mitchell, Jessica Mitchell
Institution: Mayo Clinic
ORCID: 0000-0002-7438-6626
Observed ORCID: 0000-0002-7438-6626
OpenAlex ID: A5103003131
Bolus 5-fluorouracil (5-FU) In Combination With Oxaliplatin Is Safe and Well Tolerated in Patients Who Experienced Coronary Vasospasm With Infusional 5-FU or Capecitabine
2018 · Sakti Chakrabarti, Jaskanwal Sara, et al. · Clinical Colorectal Cancer · 40
Safety and Activity of PolyPEPI1018 Combined with Maintenance Therapy in Metastatic Colorectal Cancer: an Open-Label, Multicenter, Phase Ib Study
2022 · Joleen M. Hubbard, Enikő R. Tőke, et al. · Clinical Cancer Research · 36
PDF
Patients’ Perspectives and Advice on How to Discuss Sexual Orientation, Gender Identity, and Sexual Health in Oncology Clinics
2020 · Elizabeth Cathcart-Rake, Jennifer O’Connor, et al. · American Journal of Hospice and Palliative Medicine® · 16
Tumor-Informed Circulating Tumor DNA for Minimal Residual Disease Detection in the Management of Colorectal Cancer
2024 · Oluwadunni E. Emiloju, Michael Storandt, et al. · JCO Precision Oncology · 14
PDF
Parenteral Nutrition in Patients With Advanced Cancer: Merging Perspectives From the Patient and Healthcare Provider
2011 · Jessica Mitchell, Aminah Jatoi · Seminars in Oncology · 10
Evaluation of safety, immunogenicity, and preliminary efficacy of PolyPEPI1018 off-the-shelf vaccine with fluoropyrimidine/bevacizumab maintenance therapy in metastatic colorectal cancer (mCRC) patients.
2020 · Joleen Marie Hubbard, Chiara Cremolini, et al. · Journal of Clinical Oncology · 9
Nanoliposomal irinotecan (Nal-IRI)-based chemotherapy after irinotecan -based chemotherapy in patients with pancreas cancer
2020 · Caleb J. Smith, Tanios S. Bekaii-Saab, et al. · Pancreatology · 8
Adverse Event Management Strategies
2014 · Jessica Mitchell, Taline Khoukaz, et al. · Clinical journal of oncology nursing · 5
Circulating Tumor DNA Predicts Early Recurrence Following Locoregional Therapy for Oligometastatic Colorectal Cancer
2024 · Conor D. J. O’Donnell, Nikolas Naleid, et al. · Cancers · 4
Chemotherapy Acute Infusion Reactions: A Qualitative Report of the Perspectives of Patients With Cancer
2018 · David J. Bartlett, Daniel S. Childs, et al. · American Journal of Hospice and Palliative Medicine® · 3
Prescriber adherence to antiemetic guidelines with the new agent trifluridine-tipiracil
2017 · Daniel Childs, Alison Jacobson, et al. · The Journal of Community and Supportive Oncology · 3
PDF
Completion of Genetic Testing and Incidence of Pathogenic Germline Mutation among Patients with Early-Onset Colorectal Cancer: A Single Institution Analysis
2023 · Michael H. Storandt, Kara R. Rogen, et al. · Cancers · 2
PDF
PolyPEPI1018 vaccine in combination with TAS-102 in participants with late-stage microsatellite-stable metastatic colorectal cancer (MSS mCRC): A phase Ib study to evaluate safety, tolerability, immunogenicity and efficacy (OBERTO-201).
2023 · Joleen M. Hubbard, Tyler J. Zemla, et al. · Journal of Clinical Oncology · 2
P-142 Completion of genetic testing and incidence of pathogenic germline mutation among patients with early-onset colorectal cancer, a single institution retrospective analysis
2023 · M. Storandt, K. Rogen, et al. · Annals of Oncology · 1
PDF
Phase Ib open-label study to evaluate safety, tolerability, immunogenicity, and efficacy of multiple subcutaneous injections of PolyPEPI1018 vaccine as an add-on immunotherapy to TAS-102 in participants with late-stage microsatellite-stable metastatic colorectal cancer (MSS mCRC; OBERTO-201).
2023 · Joleen M. Hubbard, Tyler J. Zemla, et al. · Journal of Clinical Oncology · 1
A retrospective study of circulating tumor DNA for minimal residual disease detection in the management of colorectal cancer.
2023 · Michael H. Storandt, Oluwadunni Eunice Emiloju, et al. · Journal of Clinical Oncology · 1
Nanoliposomal irinotecan-based chemotherapy after regular irinotecan-based chemotherapy in patients with pancreas cancer.
2021 · Caleb J Smith, Tanios S. Bekaii-Saab, et al. · Journal of Clinical Oncology · 1
PolyPEPI1018 Cancer Vaccine and TAS-102 for Patients With Advanced, Chemo-Refractory, Microsatellite-Stable Metastatic Colorectal Cancer: A Phase Ib Nonrandomized Study
2025 · Joleen M. Hubbard, Tyler Zemla, et al. · JCO oncology advances.
PDF
Prospective evaluation of the quality of life and safety in patients receiving hepatic artery infusion pump chemotherapy
2025 · LaDonna E. Kearse, Courtney Day, et al. · Surgical Oncology Insight
PDF
Systemic treatment post curative-intent intervention based on tumor-informed circulating tumor DNA result for oligometastatic colorectal cancer.
2024 · Teerada Siripoon, Conor O'Donnell, et al. · Journal of Clinical Oncology
PDF
Prognostic value of circulating tumor DNA following local therapy in colorectal cancer with liver metastases.
2024 · Conor O'Donnell, Michael H. Storandt, et al. · Journal of Clinical Oncology
PDF
Supplementary Table from Safety and Activity of PolyPEPI1018 Combined with Maintenance Therapy in Metastatic Colorectal Cancer: an Open-Label, Multicenter, Phase Ib Study
2023 · Joleen M. Hubbard, Enikő R. Tőke, et al.
PDF
Supplementary Figure from Safety and Activity of PolyPEPI1018 Combined with Maintenance Therapy in Metastatic Colorectal Cancer: an Open-Label, Multicenter, Phase Ib Study
2023 · Joleen M. Hubbard, Enikő R. Tőke, et al.
PDF
Supplementary Table from Safety and Activity of PolyPEPI1018 Combined with Maintenance Therapy in Metastatic Colorectal Cancer: an Open-Label, Multicenter, Phase Ib Study
2023 · Joleen M. Hubbard, Enikő R. Tőke, et al.
Supplementary Figure from Safety and Activity of PolyPEPI1018 Combined with Maintenance Therapy in Metastatic Colorectal Cancer: an Open-Label, Multicenter, Phase Ib Study
2023 · Joleen M. Hubbard, Enikő R. Tőke, et al.
PDF
Works count: 44
Citation count: 156
H-index: 7
I10-index: 5
Year
Topic
Type